Ignite Creation Date:
2024-05-06 @ 9:00 AM
Last Modification Date:
2024-10-26 @ 12:08 PM
Study NCT ID:
NCT02876081
Status:
WITHDRAWN
Last Update Posted:
2017-09-11
First Post:
2016-08-18
Brief Title:
Phase II Study of Afatinib as Third- or Further-line Treatment for Patients With Stage IV Bronchial Adenocarcinoma Harboring Wild-type EGFR Expressing the Neurotensin - Neurotensin Receptor Complex
Sponsor:
Fondation Hôpital Saint-Joseph
Organization:
Fondation Hôpital Saint-Joseph
Conditions & Keywords Data
Conditions:
| Name |
|---|
| SMALL CELL LUNG CARCINOMA |
Keywords: